Cargando…

Prolonged Duration of Viral Shedding of SARS-CoV-2: A Case Report

INTRODUCTION: The literature on the clinical course of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) suggests patients continue shedding viral particles typically for an average of 20 days until the body builds immunity against the infection. However, a few cases have shown prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fong, Brandon, London, Kory S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2020
Materias:	COVID-19 Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676783/ https://www.ncbi.nlm.nih.gov/pubmed/33217258 http://dx.doi.org/10.5811/cpcem.2020.7.49005

Ejemplares similares

Viral shedding patterns of symptomatic SARS-CoV-2 infections by periods of variant predominance and vaccination status in Gyeonggi Province, Korea
por: Choi, Gawon, et al.
Publicado: (2022)

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome
por: Rosas-Salazar, Christian, et al.
Publicado: (2021)

Persistent viral shedding of SARS‐CoV‐2 in faeces – a rapid review
por: Gupta, S., et al.
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Pneumonies virales épidémiques – Pneumonie à SARS-CoV-2 : où en sommes-nous ?
por: Delomez, J., et al.
Publicado: (2021)

Risk factors associated with SARS-CoV-2 transmission, outbreak duration, and mortality in Fraser Health acute-care settings
por: Duncombe, Tamara, et al.
Publicado: (2022)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
por: Zuo, Tao, et al.
Publicado: (2021)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report
por: Jaijakul, Siraya
Publicado: (2020)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

A Review of Viral Shedding in Resolved and Convalescent COVID-19 Patients
por: Karia, Rutu, et al.
Publicado: (2020)

Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report
por: Valente, Paola, et al.
Publicado: (2020)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Detected SARS-CoV-2 in Ascitic Fluid Followed by Cryptococcemia: a Case Report
por: Passarelli, Victor C., et al.
Publicado: (2020)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report
por: Gunawardhana, Champika, et al.
Publicado: (2021)

SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report
por: Bulut, Haldun, et al.
Publicado: (2021)

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
por: Reicher, Shay, et al.
Publicado: (2021)

Broken Heart (Takotsubo) Syndrome Triggered by SARS-CoV-2
por: Finsterer, Josef
Publicado: (2021)

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020
por: Morikane, Keita, et al.
Publicado: (2021)

Cognitive phenotyping of post-infectious SARS-CoV-2 patients
por: Aiello, Edoardo Nicolò, et al.
Publicado: (2022)

Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022)

Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report
por: Patrocínio de Jesus, Rita, et al.
Publicado: (2020)

Fahr’s syndrome presenting with seizures in SARS-CoV-2 (COVID-19) pneumonia—a case report
por: Demir, Gürkan, et al.
Publicado: (2020)

New daily persistent headache after SARS-CoV-2 infection: a report of two cases
por: Dono, Fedele, et al.
Publicado: (2021)

Animal Models to Study Emerging Technologies Against SARS-CoV-2
por: Mullick, Jhinuk Basu, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0jef6q0talpotr2priv3naamtm